Company page

Personalis, Inc.

Personalis, Inc. (ticker: PSNL) is a public company based in the United States, specializing in genomics and personalized medicine. With a market capitalization of approximately $1.26 billion, the company focuses on providing advanced genomic sequencing and analysis services to enhance cancer treatment and precision medicine. Personalis aims to improve patient outcomes through innovative technology and data-driven insights.